University of Rochester Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Rochester Medical Center brings 13 presentations to ASH 2026 in New Orleans. Its research centres on red cell production, bone marrow niches and acute myeloid leukemia. It includes a safety run-in of an all-oral combination for IDH2-mutated AML.
| Organization | ASH 2026 Attendance |
|---|---|
University of Rochester Medical Center Rochester, NY | |
University of Rochester's academic medical center, including Strong Memorial Hospital and the Wilmot Cancer Institute. | Talk Fri Dec 11 2:54pm–3:43pm Oral Sat Dec 12 2:00pm–3:30pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 9:30am–11:00am Oral Sun Dec 13 12:00pm–1:30pm Talk Sun Dec 13 4:30pm–5:45pm The Interplay Between Pyrimidine Synthesis and Ferroptosis in Erythropoiesis How nucleotide building interacts with an iron-driven cell death from damaged membrane fats, a major cause of failed red cell production in beta-thalassemia. Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 4:30pm–6:00pm |
Find decision makers at University of Rochester Medical Center
Tell us what you sell and we’ll find the people at University of Rochester Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction